New patent expiration for Nabriva drug XENLETA

Annual Drug Patent Expirations for XENLETA Xenleta is a drug marketed by Nabriva and is included in two NDAs. There are four patents protecting this drug. Drug patent litigation for…
The post New patent expiration for Nabriva drug XENLETA appeared firs…


Which pharmaceutical drugs have the most drug patents in Greece?

This chart shows the drugs with the most patents in Greece. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Greece? …


Biotechblog